These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15026048)

  • 21. Design and synthesis of N-alkyl oxindolylidene acetic acids as a new class of potent Cdc25A inhibitors.
    Shimazawa R; Kuriyama M; Shirai R
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3350-3. PubMed ID: 18442908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and functional evaluation of triazine-based bivalent agents that simultaneously target the active site and hot spot of phosphatase Cdc25B.
    Nagaoka Y; Parvatkar P; Hirai G; Ohkanda J
    Bioorg Med Chem Lett; 2021 Sep; 48():128265. PubMed ID: 34273487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling of Cdc25B dual specifity protein phosphatase inhibitors: docking of ligands and enzymatic inhibition mechanism.
    Lavecchia A; Cosconati S; Limongelli V; Novellino E
    ChemMedChem; 2006 May; 1(5):540-50. PubMed ID: 16892390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones.
    Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J
    J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C.
    Lavergne O; Fernandes AC; Bréhu L; Sidhu A; Brézak MC; Prévost G; Ducommun B; Contour-Galcera MO
    Bioorg Med Chem Lett; 2006 Jan; 16(1):171-5. PubMed ID: 16216500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of caulibugulones A-E.
    Wipf P; Joo B; Nguyen T; Lazo JS
    Org Biomol Chem; 2004 Aug; 2(15):2173-4. PubMed ID: 15280951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthraquinones, Cdc25B phosphatase inhibitors, isolated from the roots of Polygonum multiflorum Thunb.
    Choi SG; Kim J; Sung ND; Son KH; Cheon HG; Kim KR; Kwon BM
    Nat Prod Res; 2007 May; 21(6):487-93. PubMed ID: 17497420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel acyclic enediynes inhibit Cyclin A and Cdc25C expression and induce apoptosis phenomenon to show potent antitumor proliferation.
    Lo YH; Lin IL; Lin CF; Hsu CC; Yang SH; Lin SR; Wu MJ
    Bioorg Med Chem; 2007 Jul; 15(13):4528-36. PubMed ID: 17485212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural mechanism of oxidative regulation of the phosphatase Cdc25B via an intramolecular disulfide bond.
    Buhrman G; Parker B; Sohn J; Rudolph J; Mattos C
    Biochemistry; 2005 Apr; 44(14):5307-16. PubMed ID: 15807524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
    Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of dialkylsubstituted maleic anhydrides as novel inhibitors of Cdc25 dual specificity phosphatases.
    Brault L; Denancé M; Banaszak E; El Maadidi S; Battaglia E; Bagrel D; Samadi M
    Eur J Med Chem; 2007 Feb; 42(2):243-7. PubMed ID: 17084000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of depeptidized macrocyclic inhibitors of hepatitis C NS3-4A protease using structure-based drug design.
    Venkatraman S; Njoroge FG; Girijavallabhan VM; Madison VS; Yao NH; Prongay AJ; Butkiewicz N; Pichardo J
    J Med Chem; 2005 Aug; 48(16):5088-91. PubMed ID: 16078825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological evaluation of newly synthesized quinoline-5,8-quinones as Cdc25B inhibitors.
    Cossy J; Belotti D; Brisson M; Skoko JJ; Wipf P; Lazo JS
    Bioorg Med Chem; 2006 Sep; 14(18):6283-7. PubMed ID: 16782352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp.
    Cao S; Foster C; Brisson M; Lazo JS; Kingston DG
    Bioorg Med Chem; 2005 Feb; 13(4):999-1003. PubMed ID: 15670907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational design, synthesis and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B.
    Keinan S; Paquette WD; Skoko JJ; Beratan DN; Yang W; Shinde S; Johnston PA; Lazo JS; Wipf P
    Org Biomol Chem; 2008 Sep; 6(18):3256-63. PubMed ID: 18802630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arylstibonic acids are potent and isoform-selective inhibitors of Cdc25a and Cdc25b phosphatases.
    Mak LH; Knott J; Scott KA; Scott C; Whyte GF; Ye Y; Mann DJ; Ces O; Stivers J; Woscholski R
    Bioorg Med Chem; 2012 Jul; 20(14):4371-6. PubMed ID: 22705189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
    Park H; Bahn YJ; Ryu SE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What's new on CDC25 phosphatase inhibitors.
    Contour-Galcera MO; Sidhu A; Prévost G; Bigg D; Ducommun B
    Pharmacol Ther; 2007 Jul; 115(1):1-12. PubMed ID: 17531323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S.
    Chatterjee AK; Liu H; Tully DC; Guo J; Epple R; Russo R; Williams J; Roberts M; Tuntland T; Chang J; Gordon P; Hollenbeck T; Tumanut C; Li J; Harris JL
    Bioorg Med Chem Lett; 2007 May; 17(10):2899-903. PubMed ID: 17382545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.
    Johnston PA; Foster CA; Tierno MB; Shun TY; Shinde SN; Paquette WD; Brummond KM; Wipf P; Lazo JS
    Assay Drug Dev Technol; 2009 Jun; 7(3):250-65. PubMed ID: 19530895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.